Independent Medical Education Request for Proposals - Parkinson's Disease - Community Neurologists
Genentech funds educational initiatives to advance Parkinson’s disease science and clinical practice for community neurologists, with an emphasis on biomarkers and emerging therapies.
Funder: Genentech
Due Dates: September 4, 2026 (Full proposal deadline)
Funding Amounts: Up to $150,000 per award; single-year support; number of awards not specified.
Summary: Supports innovative educational initiatives to advance Parkinson’s disease care and knowledge among community neurologists.
Description
Genentech’s Independent Medical Education initiative for Parkinson’s Disease—focused on Community Neurologists—seeks to fund creative and impactful educational programs that address key gaps in translating advances in Parkinson’s disease science into clinical practice. The primary goal is to improve disease management, foster adoption of new diagnostic and therapeutic approaches, and ultimately enhance patient outcomes in community settings. The program targets community neurologists, aiming to increase understanding of the role of alpha-synuclein, biomarker testing, and emerging disease-modifying therapies.
